{"id":217882,"date":"2025-07-14T21:08:36","date_gmt":"2025-07-15T02:08:36","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/07\/study-finds-shorter-therapy-effective-for-some-with-drug-resistant-tuberculosis"},"modified":"2025-07-14T21:08:36","modified_gmt":"2025-07-15T02:08:36","slug":"study-finds-shorter-therapy-effective-for-some-with-drug-resistant-tuberculosis","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/07\/study-finds-shorter-therapy-effective-for-some-with-drug-resistant-tuberculosis","title":{"rendered":"Study finds shorter therapy effective for some with drug-resistant tuberculosis"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/study-finds-shorter-therapy-effective-for-some-with-drug-resistant-tuberculosis2.jpg\"><\/a><\/p>\n<p>Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others may warrant more aggressive therapy, according to the findings of a new study led by an international group of researchers, including scientists from Harvard Medical School, and conducted across six countries in Asia, Africa, and South America.<\/p>\n<p>The study is the first-ever clinical trial to focus exclusively on people with pre-extensively <a href=\"https:\/\/medicalxpress.com\/tags\/drug-resistant+tuberculosis\/\" rel=\"tag\" class=\"\">drug-resistant tuberculosis<\/a> (pre-XDR-TB), a hard-to-treat form of the disease that is more challenging to cure than multi-drug resistant TB but not as extremely impervious to medicines as the most dreaded form of the infection known as extensively drug-resistant TB.<\/p>\n<p>Pre-XDR-TB is resistant to rifampin\u2014the most potent first-line drug used against TB\u2014and fluoroquinolone, which thus far has been the most potent second-line TB drug.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others may warrant more aggressive therapy, according to the findings of a new study led by an international group of researchers, including scientists from Harvard Medical School, and conducted across six countries in Asia, Africa, and South America. The [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-217882","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/217882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=217882"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/217882\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=217882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=217882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=217882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}